HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Georges Deschênes Selected Research

Complement Factor H Deficiency

12/2016Long-term successful liver-kidney transplantation in a child with atypical hemolytic uremic syndrome caused by homozygous factor H deficiency.
11/2007Ocular involvement in hemolytic uremic syndrome due to factor H deficiency--are there therapeutic consequences?
11/2006Secondary failure of plasma therapy in factor H deficiency.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Georges Deschênes Research Topics

Disease

34Nephrotic Syndrome (Syndrome, Nephrotic)
01/2022 - 04/2000
18Proteinuria
01/2022 - 04/2000
9Renal Insufficiency (Renal Failure)
02/2022 - 03/2005
9Chronic Kidney Failure (Chronic Renal Failure)
11/2021 - 08/2006
8Cystinosis
11/2021 - 07/2012
8Bartter Syndrome (Syndrome, Bartter)
01/2019 - 08/2000
6Hypertension (High Blood Pressure)
01/2020 - 11/2006
5Nephrocalcinosis
02/2022 - 08/2000
5Hyperoxaluria (Oxaluria)
02/2022 - 01/2017
5Infections
01/2018 - 04/2008
4Nephrosis
12/2005 - 04/2000
4Ascites
12/2005 - 04/2000
3Primary hyperoxaluria type 1
02/2022 - 01/2021
3Kidney Calculi (Kidney Stone)
02/2022 - 01/2021
3Edema (Dropsy)
01/2021 - 11/2001
3Chronic Renal Insufficiency
01/2020 - 01/2018
3Acute Kidney Injury (Acute Renal Failure)
01/2019 - 04/2008
3Atypical Hemolytic Uremic Syndrome
01/2019 - 04/2013
3Polyhydramnios
04/2017 - 03/2010
3Hyperaldosteronism (Conn Syndrome)
04/2017 - 08/2006
3Polyuria
04/2017 - 03/2010
3Dehydration (Water Stress)
04/2017 - 01/2016
3Complement Factor H Deficiency
12/2016 - 11/2006
3Membranous Glomerulonephritis (Membranous Nephropathy)
06/2011 - 06/2002
2Autoimmune Diseases (Autoimmune Disease)
01/2022 - 01/2022
2Rare Diseases (Rare Disease)
11/2021 - 01/2021
2Primary Hyperoxaluria (Oxaluria, Primary)
01/2021 - 01/2017
2Inborn Genetic Diseases (Disease, Hereditary)
01/2021 - 01/2017
2Albuminuria
01/2019 - 12/2005
2Kidney Diseases (Kidney Disease)
01/2019 - 04/2013
2Weight Gain
12/2018 - 07/2015
2Thrombotic Microangiopathies
09/2018 - 11/2007
2Pain (Aches)
01/2018 - 11/2007
2Hypernatremia
01/2018 - 01/2018
2Pancreatitis
01/2018 - 01/2018
2Lupus Nephritis
01/2018 - 02/2008
2Neoplasms (Cancer)
12/2017 - 12/2002
2Fever (Fevers)
08/2015 - 04/2008
2Anemia
08/2015 - 01/2009
2Cytomegalovirus Infections (Inclusion Disease)
04/2014 - 06/2012
2Membranoproliferative Glomerulonephritis (Membranoproliferative Glomerulonephritis, Type II)
01/2014 - 03/2011
2Alkalosis
01/2011 - 08/2000
1Agammaglobulinemia (Hypogammaglobulinemia)
01/2021
1Disease Progression
01/2021

Drug/Important Bio-Agent (IBA)

17SteroidsIBA
01/2020 - 01/2006
12Rituximab (Mabthera)FDA Link
01/2022 - 09/2009
11SodiumIBA
01/2021 - 04/2000
10SaltsIBA
01/2020 - 08/2000
8AntibodiesIBA
01/2022 - 06/2002
6OxalatesIBA
02/2022 - 01/2017
5Immunoglobulin G (IgG)IBA
01/2022 - 02/2008
5Cystine (L-Cystine)IBA
11/2021 - 07/2012
5Cysteamine (Mercaptamine)FDA Link
11/2021 - 07/2012
5Complement System Proteins (Complement)IBA
01/2019 - 11/2007
5Proteins (Proteins, Gene)FDA Link
01/2018 - 04/2000
5AldosteroneIBA
04/2017 - 03/2001
4Prednisone (Sone)FDA LinkGeneric
01/2019 - 01/2006
4Tacrolimus (Prograf)FDA LinkGeneric
01/2018 - 04/2000
4Mycophenolic Acid (Cellcept)FDA LinkGeneric
01/2018 - 01/2006
4Complement Factor H (Factor H)IBA
12/2016 - 11/2006
3EnzymesIBA
02/2022 - 06/2011
3AutoantibodiesIBA
01/2022 - 01/2006
3Intravenous Immunoglobulins (IVIG)FDA Link
01/2021 - 01/2019
3Pharmaceutical PreparationsIBA
04/2020 - 10/2007
3CreatinineIBA
01/2019 - 11/2006
3Puromycin AminonucleosideIBA
07/2011 - 11/2001
3Cyclosporine (Ciclosporin)FDA LinkGeneric
10/2007 - 04/2000
3Adenosine Triphosphatases (ATPase)IBA
12/2005 - 04/2000
2Fc(alpha) receptorIBA
01/2022 - 02/2008
2Immunoglobulin A (IgA)IBA
01/2022 - 02/2008
2Monoclonal AntibodiesIBA
01/2022 - 12/2016
2lumasiranIBA
01/2021 - 01/2021
2Calcineurin InhibitorsIBA
01/2019 - 06/2010
2Adrenal Cortex Hormones (Corticosteroids)IBA
01/2018 - 12/2005
2ElectrolytesIBA
01/2018 - 01/2016
2Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric
01/2018 - 04/2008
2PotassiumIBA
01/2018 - 07/2011
2AntigensIBA
01/2017 - 06/2011
2Albendazole (Albenza)FDA Link
01/2016 - 08/2015
2DNA (Deoxyribonucleic Acid)IBA
08/2015 - 12/2014
2Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
08/2015 - 11/2006
2Immunoglobulin M (IgM)IBA
08/2015 - 12/2014
2ValganciclovirFDA Link
04/2014 - 06/2012
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
06/2011 - 12/2005
2Biological ProductsIBA
01/2011 - 11/2006
2Retinaldehyde (Retinal)IBA
11/2007 - 10/2002
2HaptoglobinsIBA
11/2006 - 03/2005
2Amiloride (Midamor)FDA LinkGeneric
12/2005 - 03/2001
2Neprilysin (Neutral Endopeptidase)IBA
06/2003 - 06/2002
1Galactose (Galactopyranose)FDA LinkGeneric
01/2022
1daratumumabIBA
01/2021

Therapy/Procedure

15Therapeutics
11/2021 - 03/2001
11Kidney Transplantation
02/2022 - 10/2002
6Renal Dialysis (Hemodialysis)
12/2018 - 08/2006
4Plasma Exchange
01/2014 - 12/2005
3Transplantation
02/2022 - 07/2017
3Peritoneal Dialysis
01/2018 - 08/2006
2Sodium-Restricted Diet (Diet, Sodium Restricted)
01/2020 - 07/2011
2Renal Replacement Therapy (Therapies, Renal Replacement)
01/2019 - 09/2018
1RNAi Therapeutics
01/2021